{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:35:40Z","timestamp":1762144540956},"reference-count":92,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,4,20]],"date-time":"2007-04-20T00:00:00Z","timestamp":1177027200000},"content-version":"vor","delay-in-days":3000,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc electrophysiol"],"published-print":{"date-parts":[[1999,2]]},"abstract":"<jats:p>Current Antiarrhythmic Drugs. Reorientation in drug therapy to control cardiac arrhythmias continues to evolve in the wake of ongoing refinements in techniques and indications for radiofrequency ablation and the use of implantable devices for atrial and ventricular arrhythmias. The role of sodium channel blockers continues to be questioned, and data from clinical trials indicate that the use of this class of drugs should be limited to control symptoms in patients who have arrhythmias and either no or minimal heart disease. The decline in the use of sodium channel Blockers has led to greater use of beta blockers and complex Class III agents, such as sotalol and amiodarone, as both primary therapy and adjunctive therapy with implantable defibrillators in patients with cardiac disease of varying degrees of ventricular dysfunction. Success with these Class III agents in the context of their side effects has led to the synthesis and characterization of compounds with simpler ion channel\u2010blocking properties. The need for such compounds stemmed from the observation that atrial fibrillation (AF) as an arrhythmia is, for the most part, still not amenable to curative therapy by interventional procedures. The isolated block of the rapid component of the delayed rectifier current (I<jats:sub>kr<\/jats:sub>) has been found to have either a neutral (e.g., dofetilide) or deleterious (e.g., d\u2010sotalol) effect on mortality in survivors of myocardial infarction. Thus, the objective of drug development should he the appropriate match between the substrate and an antiarrhythimic drug. The so\u2010called pure Class III agents have been shown to have beneficial antifibrillatory effects in patients with AF. They are effective in inducing acute chemical conversion, preventing paroxysmal AF, and maintaining sinus rhythm in patients with persistent AF restored to sinus rhythm with DC cardioversion. AF is a complex arrhythmia, undoubtedly a result of multifaceted derangement of atrial ionic currents. Attention has therefore focused on newer compounds that have the propensity to block more than one ion channel. Examples of such agents are tedisamil and azimilide, the latter having been studied extensively in humans. It is the first of the Class 111 agents that block both components (I<jats:sub>Kr<\/jats:sub>) and I<jats:sub>Ks<\/jats:sub>) of the delayed rectifier current, which results in a spectrum of electrophysiologic properties that includes lack of rate or use dependency in terms of effect on repolarization and refractoriness of atrial and ventricular myocardium. Available but unpublished clinical data indicate that azimilide may be effective over a wide range of tachycardia cycle lengths with a low incidence of torsades de pointes. In these respects, its properties, at least in terms of its use in AF, resemble those of amiodarone. However, the drug has little or no effect on AV conduction, which precludes the modulation of ventricular response in patients relapsing to AF.<\/jats:p>","DOI":"10.1111\/j.1540-8167.1999.tb00674.x","type":"journal-article","created":{"date-parts":[[2007,4,20]],"date-time":"2007-04-20T14:16:12Z","timestamp":1177078572000},"page":"283-301","source":"Crossref","is-referenced-by-count":68,"title":["Current Antiarrhythmic Drugs"],"prefix":"10.1111","volume":"10","author":[{"given":"BRAMAH N.","family":"SINGH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,20]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(83)80065-5"},{"key":"e_1_2_1_3_2","first-page":"4G","article-title":"Controlling cardiac arrhythmia","volume":"80","author":"Singh BN","journal-title":"An overview"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.86.3.1033"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908103210629"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207233270403"},{"key":"e_1_2_1_7_2","unstructured":"SinghBN:Pharmacological Actions of Certain Cardiac Drugs and Hormones: Focus on Antiarrhythmic Mechanisms.Doctoral Thesis Hertford College and University of Oxford England 1971 Futura Publishing Co. Inc. Armonk. NY 1991 pp.1\u201398."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1970.tb09893.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1970.tb09891.x"},{"key":"e_1_2_1_10_2","first-page":"440","volume-title":"Symposium on Cardiac Arrhythmias","author":"Vaughan Williams EM","year":"1970"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/6.2.109"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199141050-00002"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(74)90080-5"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-2595-6_4"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/17.6.344"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(75)90431-7"},{"key":"e_1_2_1_17_2","first-page":"S233","article-title":"Approaches to prevention of sudden death: Need for fundamental reevaluation","volume":"2","author":"Yusuf S","year":"1991","journal-title":"J Cardiovasc Electrophysiol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00449-3"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00147-7"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.4.1831"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1999.tb00673.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00561-0"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90490-C"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.4.1106"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90003-6"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.5.1977"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308123290701"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308123290702"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90673-Z"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.8.2195"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00471-8"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(85)90626-X"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210013271404"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-0620(85)80003-7"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2793"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.4.1765"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09145-3"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)08171-8"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/107424849800300310"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90194-6"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(97)00114-4"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1995.tb00365.x"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/14.suppl_H.14"},{"key":"e_1_2_1_44_2","volume-title":"Clinical Trials in Mortality Reduction in Patients with Cardiovascular Disease","author":"Singh BN","year":"1999"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001573-199401000-00003"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)92225-5"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.6.1932"},{"key":"e_1_2_1_48_2","article-title":"The effects of antiarrhythmic therapy in maintaining stability of sinus rhythm in atrial fibrillation","volume":"399","author":"The SAEE\u2010T Investigators","year":"1997","journal-title":"VA Cooperative"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90188-Q"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1997.0838"},{"key":"e_1_2_1_51_2","first-page":"801","article-title":"Can we predict atrial fibrillation after coronary artery surgery and why should we","volume":"19","author":"Hohnloser SH","year":"1998","journal-title":"(Editorial) Eur Heart J"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91048-0"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00452-3"},{"key":"e_1_2_1_54_2","first-page":"187","article-title":"Differential electro\u2013physiologic effects of chronically administered amiodarone on canine Purkinje fibers versus ventricular muscle","volume":"1","author":"Papp JGY","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1997.tb01018.x"},{"key":"e_1_2_1_56_2","first-page":"465","article-title":"Effects of amiodarone, sematilide and sotalol on QT dispersion","volume":"75","author":"Cui G","year":"1995","journal-title":"Am J Cardiol"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.3.1063"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90205-4"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-7-199410010-00009"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.11.3255"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.11.3264"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1177\/107424849600100206"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80799-1"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)91134-4"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90960-P"},{"key":"e_1_2_1_66_2","article-title":"Intravenous amiodarone reduces CABG hospitalization: The ARCH trial. Presentation at the NASPE Annual Scientific Meeting","author":"Guarnieri T","year":"1998","journal-title":"San Diego"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712183372501"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.6.2235"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199508000-00012"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.1997.tb00328.x"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-7-199410010-00009"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02149-6"},{"key":"e_1_2_1_73_2","volume-title":"Preliminary results presented at the European Congress of Cardiology","author":"Danish Trial in Acute Myocardial Infarction on Dofetilide (DIAMOND)","year":"1997"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00506-2"},{"key":"e_1_2_1_75_2","first-page":"383","article-title":"and the Dofetilide Atrial Fibrillation Investigators: Efficacy and safety of oral dofetilide in maintaining normal sinus rhythm in patients with atrial fibrillation\/flutter: A multicenter study","volume":"96","author":"Singh SN","year":"1997","journal-title":"Circulation"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.7.1613"},{"key":"e_1_2_1_77_2","first-page":"391","article-title":"Acute conversion of atrial flutter and fibrillation: Direct current cardioversion versus intravenously administered pure class Hi agents","volume":"29","author":"Singh BN","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(85)90629-5"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.7.1499"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1177\/107424849700200405"},{"key":"e_1_2_1_81_2","first-page":"231P","article-title":"Tedisamil possesses direct defibrillatory activity during myocardial ischemia and during reperfusion","volume":"99","author":"Tsuchihashi K","year":"1990","journal-title":"(Abstract) Br J Pharmacol"},{"key":"e_1_2_1_82_2","first-page":"III","article-title":"Chemical defibrillation in ischemia and reperfusion by selective blockade of the transient outward current (Ito)","volume":"82","author":"Tsuchihashi K","year":"1991","journal-title":"(Abstract) Circulation"},{"key":"e_1_2_1_83_2","first-page":"H1746","article-title":"Tedisamil inactivates transient outward K+ channels in rat and guinea pig ventricular myocytes","volume":"257","author":"Dukes ID","year":"1989","journal-title":"Am J Physiol"},{"key":"e_1_2_1_84_2","first-page":"560","article-title":"Tedisamil blocks the transient and delayed rectifier K+currents in mammalian cardiac and glial cells","volume":"254","author":"Dukes ID","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_85_2","first-page":"1","article-title":"Azimilide (NE\u2010i0064) blocks outward K currents in human atrial and ventricular myocytes","volume":"92","author":"Lamorgese M","year":"1997","journal-title":"(Abstract) Circulation"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1999.tb00676.x"},{"key":"e_1_2_1_87_2","first-page":"A97","article-title":"Effects of intravenously administered NE\u201010064 on programmed electrical stimulation (PES)\u2010induced ventricular arrhythmias in anesthetized infarcted dogs","volume":"7","author":"Drexler AP","year":"1993","journal-title":"(Abstract) FASEB J"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199312000-00006"},{"issue":"2","key":"e_1_2_1_89_2","first-page":"664","article-title":"Antiarrhythmic efticacy of azimilide dihydrocloride on functional circus movement atrial flutter in the canine right atriat enlargement model","author":"Restivo M","year":"1996","journal-title":"PACE"},{"key":"e_1_2_1_90_2","first-page":"205","article-title":"Azimilide pharmacokinetics and pharmacodynamics upon multiple oral dosing","volume":"61","author":"Corey AE","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.1.274"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.7.1954"},{"key":"e_1_2_1_93_2","first-page":"30C","article-title":"impact of managed care on the treatment of atrial fibrillation","volume":"18","author":"Pratt CM","year":"1988","journal-title":"Am J Cardiol"}],"container-title":["Journal of Cardiovascular Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8167.1999.tb00674.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8167.1999.tb00674.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T17:26:25Z","timestamp":1698513985000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8167.1999.tb00674.x"}},"subtitle":["An Overview of Mechanisms of Action and Potential Clinical Utility"],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["10.1111\/j.1540-8167.1999.tb00674.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8167.1999.tb00674.x","archive":["Portico"],"relation":{},"ISSN":["1045-3873","1540-8167"],"issn-type":[{"value":"1045-3873","type":"print"},{"value":"1540-8167","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}